CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury

Experimental Neurology

Volumn 231, Issue 2, 2011, Pages 272-283

  Bao, Feng ^a   Brown, Arthur ^a   Dekaban, Gregory A ^a   Omana, Vanessa ^a   Weaver, Lynne C ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Anti integrin treatment; Kidney; Liver; Lung; Organ damage; Spinal cord injury; Systemic inflammatory response

Indexed keywords

CD11 ANTIGEN; CD11D ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD11D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG TARGETING; FEMALE; INFLAMMATION; KIDNEY; LEUKOCYTE MIGRATION; LIPID PEROXIDATION; LIVER; LUNG; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NITRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SPINAL CORD INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORACIC SPINAL CORD; TRANSCRIPTION REGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11; KIDNEY; LIPID PEROXIDATION; MACROPHAGES; NEUTROPHILS; RATS; RATS, WISTAR; SPINAL CORD; SPINAL CORD INJURIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORACIC VERTEBRAE;

EID: 80052546336     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.07.001     Document Type: Article

References (51)

1. Acosta J.A., Yang J.C., Winchell R.J., Simons R.K., Fortlage D.A., Hollingsworth-Fridlund P., Hoyt D.B. Lethal injuries and time to death in a level I trauma center. J. Am. Coll. Surg. 1998, 186:528-533.
2. Anthony D., Dempster R., Fearn S., Clements J., Wells G., Perry V.H., Walker K. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr. Biol. 1998, 8:923-926.
3. Bao F., Chen Y., Dekaban G.A., Weaver L.C. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J. Neurochem. 2004, 88:1335-1344.
4. Bao F., Dekaban G.A., Weaver L.C. Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J. Neurochem. 2005, 94:1361-1373.
5. Bao F., Bailey C.S., Gurr K.R., Bailey S.I., Rosas-Arellano M.P., Dekaban G.A., Weaver L.C. Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury. Exp. Neurol. 2009, 215(2):308-316.
6. Bao F., Bailey C.S., Gurr K.R., Bailey S.I., Rosas-Arellano M.P., Brown A., Dekaban G.A., Weaver L.C. Human spinal cord injury causes specific increases in surface expression of Beta integrins on leukocytes. J. Neurotrauma 2011, 28(2):269-280.
7. Baskaran H., Yarmush M.L., Berthiaume F. Dynamics of tissue neutrophil sequestration after cutaneous burns in rats. J. Surg. Res. 2000, 93(1):88-96.
8. Bhatia R.K., Pallister I., Dent C., Jones S.A., Topley N. Enhanced neutrophil migratory activity following major blunt trauma. Injury 2005, 36(8):956-962.
9. Blight A.R. Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 1992, 9(Supp 1):S83-S91.
10. Campbell S.J., Hughes P.M., Iredale J.P., Wilcockson D.C., Waters S., Docagne F., Perry V.H., Anthony D.C. CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J. 2003, 17(9):1168-1170.
11. Campbell S.J., Perry V.H., Pitossi F.J., Butchart A.G., Chertoff M., Waters S., Dempster R., Anthony D.C. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am. J. Pathol. 2005, 166:1487-1497.
12. Catz A., Thaleisnik M., Fishel B., Ronen J., Spasser R., Fredman B., Shabtay E., Gepstein R. Survival following spinal cord injury in Israel. Spinal Cord 2002, 40(11):595-598.
13. Comporti M., Arezzini B., Signorini C., Vecchio D., Gardi C. Oxidative stress, isoprostanes and hepatic fibrosis. Histol. Histopathol.: Cell. Mol. Biol. 2009, 24:893-900.
14. Cruse J.M., Lewis R.E., Bishop G.R., Kliesch W.F., Gaitan E. Neuroendocrine-immune interactions associated with loss and restoration of immune system function in spinal cord injury and stroke patients. Immunol. Res. 1992, 11(2):104-116.
15. Cruse J.M., Keith J.C., Bryant M.L., Lewis R.E. Immune system-neuroendocrine dysregulation in spinal cord injury. Immunol. Res. 1996, 15(4):306-314.
16. Cruse J.M., Lewis R.E., Dilioglou S., Roe D.L., Wallace W.F., Chen R.S. Review of immune function, healing of pressure ulcers, and nutritional status in patients with spinal cord injury. J. Spinal Cord Med. 2000, 23(2):129-135.
17. DeVivo M.J., Krause J.S., Lammertse D.P. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch. Phys. Med. Rehabil. 1999, 80(11):1411-1419.
18. Ditor D.S., Bao F., Chen Y., Dekaban G.A., Weaver L.C. A therapeutic time window for anti-CD11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury. J. Neurosurg. Spine 2006, 5:343-352.
19. Fleming J.C., Norenberg M.D., Ramsay D.A., Dekaban G.A., Marcillo A.E., Saenz A.D., Pasquales-Style M., Dietrich W.D., Weaver L.C. The cellular inflammatory response in human spinal cords after injury. Brain 2006, 129(Pt 12):3249-3269.
20. Fleming J.C., Bao F., Chen Y., Hamilton E.F., Relton J.K., Weaver L.C. α4β1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Exp. Neurol. 2008, 214(2):147-159.
21. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340(6):448-454.
22. Grayson M.H., Van der Vieren M., Sterbinsky S.A., Gallatin W.M., Hoffman P.A., Staunton D.E., Bochner B.S. αdβ2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1). J. Exp. Med. 1998, 188:2187-2191.
23. Gris D., Marsh D.R., Oatway M.A., Chen Y., Hamilton E.F., Dekaban G.A., Weaver L.C. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J. Neurosci. 2004, 24:4043-4051.
24. Gris D., Hamilton E.F., Weaver L.C. The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp. Neurol. 2008, 211:259-270.
25. Hundt H., Fleming J.C., Phillips J.T., Lawendy A., Gurr K.R., Bailey S.I., Sanders D., Bihari R., Gray D., Parry N., Bailey C.S., Badhwar A. Assessment of hepatic inflammation after spinal cord injury using intravital microscopy. Injury 2011, 10.1016/j.injury.2010.12.013.
26. Johnson M. Effects of beta2-agonists on resident and infiltrating inflammatory cells. J. Allergy Clin. Immunol. 2002, 110(6 Suppl):S282-S290.
27. Kyono W., Coates T.D. A practical approach to neutrophil disorders. Pediatr. Clin. North Am. 2002, 49(5):929-971. viii.
28. Lenz A., Franklin G.A., Cheadle W.G. Systemic inflammation after trauma. Injury 2007, 38(12):1336-1345.
29. Lucin K.M., Sanders V.M., Jones T.B., Malarkey W.B., Popovich P.G. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp. Neurol. 2007, 207(1):75-84.
30. Maiorov D.N., Weaver L.C., Krassioukov A.V. Relationship between sympathetic activity and arterial pressure in conscious spinal rats. Am. J. Physiol. 1997, 272:H625-H631.
31. Mathias C.J., Christensen N.J., Corbett J.L., Frankel H.L., Goodwin T.J., Peart W.S. Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted. Clin. Sci. Mol. Med. 1975, 49:291-299.
32. McKinley W.O., Jackson A.B., Cardenas D.D., DeVivo M.J. Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch. Phys. Med. Rehabil. 1999, 80:1402-1410.
33. Oatway M.A., Chen Y., Bruce J.C., Dekaban G.A., Weaver L.C. An anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate and ventral horns of the injured spinal cord. J. Neurosci. 2005, 25:637-647.
34. O'Connor P.J. Survival after spinal cord injury in Australia. Arch. Phys. Med. Rehabil. 2005, 86(1):37-47.
35. Ott L., McClain C.J., Gillespie M., Young B. Cytokines and metabolic dysfunction after severe head injury. J. Neurotrauma 1994, 11(5):447-472.
36. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 2003, 4(2):103-112.
37. Pickett G.E., Campos-Benitez M., Keller J.L., Duggal N. Epidemiology of traumatic spinal cord injury in Canada. Spine 2006, 31(7):799-805.
38. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 1997, 377:443-464.
39. Rosas-Ballina M., Tracey K.J. Cholinergic control of inflammation. J. Intern. Med. 2009, 265(6):663-679.
40. Ryugo M., Sawa Y., Takano H., Matsumiya G., Iwai S., Ono M., Hata H., Yamauchi T., Nishimura M., Fujino Y., Matsuda H. Effect of a polymorphonuclear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: findings of a double-blind randomized study. Surg. Today 2006, 36(4):321-326.
41. Saville L.R., Pospisil C.H., Mawhinney L.A., Bao F., Simedria F.C., Peters A.A., O'Connell P.J., Weaver L.C., Dekaban G.A. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment. J. Neuroimmunol. 2004, 156:42-57.
42. Snedecor G., Cochran W.G. Statistical Methods 1989, Iowa State University Press, Iowa. 8 ed.
43. Taoka Y., Okajima K., Uchiba M., Murakami K., Kushimoto S., Johno M., Naruo M., Okabe H., Takatsuki K. Role of neutrophils in spinal cord injury in the rat. Neuroscience 1997, 79(4):1177-1182.
44. Trabold B., Gruber M., Frohlich D. Functional and phenotypic changes in polymorphonuclear neutrophils induced by catecholamines. Scand. Cardiovasc. J. 2007, 41(1):59-64.
45. Van der Vieren M., Trong H.L., Wood C.L., Moore P.F., St.John T., Staunton D.E., Gallatin W.M. A novel leukointegrin, αdβ2, binds preferentially to ICAM-3. Immunity 1995, 3:683-690.
46. Van der Vieren M., Crowe D.T., Hoekstra D., Vazeux R., Hoffman P.A., Grayson M.H., Bochner B.S., Gallatin W.M., Staunton D.E. The leukocyte integrin αDβ2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. J. Immunol. 1999, 163:1984-1990.
47. Wahle M., Greulich T., Baerwald C.G., Hantzschel H., Kaufmann A. Influence of catecholamines on cytokine production and expression of adhesion molecules of human neutrophils in vitro. Immunobiology 2005, 210(1):43-52.
48. Wang C.X., Olschowka J., Wrathall J.R. Increase of interleukin-1β mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res. 1997, 759:190-196.
49. Weaver L.C., Verghese P., Bruce J.C., Fehlings M.G., Krenz N.R., Marsh D.R. Autonomic dysreflexia and primary afferent sprouting after clip-compression injury of the rat spinal cord. J. Neurotrauma 2001, 18:1107-1119.
50. Wilcockson D.C., Campbell S.J., Anthony D.C., Perry V.H. The systemic and local acute phase response following acute brain injury. J. Cereb. Blood Flow Metab. 2002, 22(3):318-326.
51. Yasui K., Kobayashi N., Yamazaki T., Agematsu K., Matsuzaki S., Nakata S., Baba A. Differential effects of short-acting beta2-agonists on human granulocyte functions. Int. Arch. Allergy Immunol. 2006, 139(1):1-8.